Evaluation of Flexofytol® PLUS in Hand Joint Chronic Dyscomfort. (NCT05089318) | Clinical Trial Compass
CompletedNot Applicable
Evaluation of Flexofytol® PLUS in Hand Joint Chronic Dyscomfort.
Belgium239 participantsStarted 2019-09-01
Plain-language summary
The purpose of this study is to evaluate the effect of curcuminoids and Boswellia serrata extracts combination (Flexofytol PLUS) in support to standard treatments during a 12-weeks period on hand pain on people with chronic hand joint discomfort.
Who can participate
Age range45 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Older dan 45 years old,
* With hand joint chronic discomfort,
* Regularly uses of paracetamol or NSAIDs to manage pain,
* Painful symptoms must have been present for more than 6 months,
* The patient assesses their pain on a visual pain scale and must be greater than 4 out of 10 over the last 48 hours.
Exclusion Criteria:
* Related to previous and associated treatments:
* Corticosteroids injection in the 3 previous months, whatever the joint concerned,
* Use of Slow-acting drugs for OA and/or dietary supplements taken within less than 6 months prior to the study (ex: chondroitin sulfate, diacerein, soy and avocado unsaponifiables, oxaceprol, granions de cuivre, glucosamine, phytotherapy or homeopathy for hand joint discomfort..),
* Anticoagulant (coumarinic) treatment and heparin,
* General corticotherapy in the 3 previous months,
* Contraindication to paracetamol, curcumin, boswellia and NSAID's.
* Related to associated pathologies:
* Patient suffering from serious associated illness (liver failure, kidney failure, non-controlled cardiovascular diseases...),
* The patient has rheumatoid arthritis or gout,
* The patient has a bile obstruction.
* Related to patient:
* Pregnant or breastfeeding women.